FDA approves first ALS drug in 5 years after pleas from patients - The Washington Post

The newly approved therapy, called AMX0035, is designed to slow the disease by protecting nerve cells in the brain and spinal cord destroyed by ALS.
The Food and Drug Administration on Thursday overcame doubts from agency scientists and approved a fiercely debated drug for ALS, a move that heartened patients and advocates who pushed for themedica… [+9877 chars] Read More